Literature DB >> 31820333

Vascular Pathways of Testosterone: Clinical Implications.

Margarida Lorigo1, Melissa Mariana1, Nelson Oliveira2, Manuel C Lemos1, Elisa Cairrao3.   

Abstract

Cardiovascular diseases (CVD) are one of the leading causes of death worldwide. Testosterone (T) is an important sex hormone that triggers several genomic and non-genomic pathways, leading to improvements of several cardiovascular risk factors and quality of life in men. At the vascular level, the key effect of T is the vasorelaxation. This review discusses the molecular pathways and clinical implications of T in the vascular system. Firstly, the mechanisms involved in the T vasodilator effect will be presented. Then, it will be discussed the association of T with the main risks for CVD, namely metabolic syndrome, type 2 diabetes mellitus, obesity, atherosclerosis, dyslipidaemia and hypertension. Several studies have shown a correlation between low T levels and an increased prevalence of several CVD. These observations suggest that T has beneficial effects on the cardiovascular system and that testosterone replacement therapy may become a therapeutic reality for some of these disorders. Graphical abstract .

Entities:  

Keywords:  Androgens; Atherosclerosis; Blood pressure; Cardiovascular diseases; Diabetes mellitus; Dyslipidaemia; Metabolic syndrome; Obesity; Risk factors; Vasorelaxation

Year:  2019        PMID: 31820333     DOI: 10.1007/s12265-019-09939-5

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  171 in total

1.  The relationship between risk factors and testosterone-induced relaxations in human internal mammary artery.

Authors:  Oguzhan Yildiz; Melik Seyrek; Ismail Un; Husamettin Gul; Goknur Candemir; Vedat Yildirim
Journal:  J Cardiovasc Pharmacol       Date:  2005-01       Impact factor: 3.105

2.  PKG is involved in testosterone-induced vasorelaxation of human umbilical artery.

Authors:  Elisa Cairrão; António José Santos-Silva; Ignacio Verde
Journal:  Eur J Pharmacol       Date:  2010-05-02       Impact factor: 4.432

3.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

4.  Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel.

Authors:  V P Deenadayalu; R E White; J N Stallone; X Gao; A J Garcia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-10       Impact factor: 4.733

Review 5.  Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.

Authors:  Yukihito Higashi
Journal:  Int J Urol       Date:  2017-03-22       Impact factor: 3.369

6.  Relationship between Serum Testosterone and Cardiovascular Disease Risk Determined Using the Framingham Risk Score in Male Patients with Sexual Dysfunction.

Authors:  Wan Chul Lee; Ma Tae Kim; Kyung Tae Ko; Won Ki Lee; Sung Yong Kim; Ha Young Kim; Dae Yul Yang
Journal:  World J Mens Health       Date:  2014-12-29       Impact factor: 5.400

Review 7.  Regulation of the adrenal androgen biosynthesis.

Authors:  William E Rainey; Yasuhiro Nakamura
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-11       Impact factor: 4.292

8.  Endogenous hormones and carotid atherosclerosis in elderly men.

Authors:  A W van den Beld; M L Bots; J A M L L Janssen; H A P Pols; S W J Lamberts; D E Grobbee
Journal:  Am J Epidemiol       Date:  2003-01-01       Impact factor: 4.897

Review 9.  Obesity: Risk factors, complications, and strategies for sustainable long-term weight management.

Authors:  Sharon M Fruh
Journal:  J Am Assoc Nurse Pract       Date:  2017-10       Impact factor: 1.495

Review 10.  The Global Epidemic of the Metabolic Syndrome.

Authors:  Mohammad G Saklayen
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

View more
  6 in total

1.  Editorial: Gender Differences in Cardiovascular Diseases.

Authors:  Qiulian Zhou; Yihua Bei
Journal:  J Cardiovasc Transl Res       Date:  2020-02       Impact factor: 4.132

Review 2.  Correlation between nongenomic action of C19-steroids and COVID-19 severity.

Authors:  M Perusqía
Journal:  Physiol Res       Date:  2021-12-14       Impact factor: 1.881

3.  Study of the Mechanism of Action of Guanxin Shutong Capsules in the Treatment of Coronary Heart Disease Based on Metabolomics.

Authors:  Dan Wang; Chang Shi; Zhen-Hua Ge; Yu-Xi Wei; Tian-Tian Liu; Yue Wang; Xin-Feng Zhou; Zi-Jun Yang; Wei-Ting Wang; Yan-Wen Zhang; Xue-Hui Zhu; Jun Zhang; Ying Li; Min Gong; Xiao-Hui Wu; Hong-Quan Duan
Journal:  Front Pharmacol       Date:  2021-03-25       Impact factor: 5.810

4.  miR-1283 Contributes to Endoplasmic Reticulum Stress in the Development of Hypertension Through the Activating Transcription Factor-4 (ATF4)/C/EBP-Homologous Protein (CHOP) Signaling Pathway.

Authors:  Weihao Chen; Tianhao Liu; Qiuer Liang; Xudong Chen; Wencong Tao; Meixia Fang; Ya Xiao; Liguo Chen
Journal:  Med Sci Monit       Date:  2021-04-29

5.  The Role of Adiponectin in the Resolution of Male-Obesity-Associated Secondary Hypogonadism after Metabolic Surgery and Its Impact on Cardiovascular Risk.

Authors:  Pilar Cobeta; Roberto Pariente; Alvaro Osorio; Marta Marchan; Marta Cuadrado-Ayuso; David Pestaña; Julio Galindo; José I Botella-Carretero
Journal:  Biomedicines       Date:  2022-08-17

6.  Vitamin D Deficiency Reduces Vascular Reactivity of Coronary Arterioles in Male Rats.

Authors:  Zoltán Fontányi; Réka Eszter Sziva; Éva Pál; Leila Hadjadj; Anna Monori-Kiss; Eszter Mária Horváth; Rita Benkő; Attila Magyar; Andrea Heinzlmann; Zoltán Benyó; György L Nádasy; Gabriella Masszi; Szabolcs Várbíró
Journal:  Curr Issues Mol Biol       Date:  2021-05-07       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.